S, P., L, Z., AM, S., & A, D. (2025). Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797). The journal of pathology. Clinical research, 11(6), e70051. https://doi.org/10.1002/2056-4538.70051
Chicago Style (17th ed.) CitationS, Parry, Zabaglo L, Shaaban AM, and Dodson A. "Inter-rater Agreement of HER2-low Scores Between Expert Breast Pathologists and the Visiopharm Digital Image Analysis Application (HER2 APP, CE2797)." The Journal of Pathology. Clinical Research 11, no. 6 (2025): e70051. https://doi.org/10.1002/2056-4538.70051.
MLA (9th ed.) CitationS, Parry, et al. "Inter-rater Agreement of HER2-low Scores Between Expert Breast Pathologists and the Visiopharm Digital Image Analysis Application (HER2 APP, CE2797)." The Journal of Pathology. Clinical Research, vol. 11, no. 6, 2025, p. e70051, https://doi.org/10.1002/2056-4538.70051.